Heffter Research Institute
The research funding organization that supported the early modern psilocybin studies at Johns Hopkins and NYU when no other funding source would — the quiet institutional backbone of the clinical research renaissance.
Type: research
Location: Santa Fe, New Mexico
Membership: Research organization — not open membership
Venues: Partner university research sites
Activities: Psilocybin research funding, grant-making to academic investigators
About
The Heffter Research Institute was founded in 1993 by pharmacologist David Nichols and several colleagues to fund and support clinical research into psychedelic compounds. Named after Arthur Heffter, the German pharmacologist who identified mescaline in 1897, Heffter has operated for three decades as a grant-making and research-coordinating organization.
Heffter's most significant contributions: it provided crucial early funding for the Johns Hopkins psilocybin program before any government or major philanthropic funding was available. Without Heffter grants, Roland Griffiths' 2006 landmark study might not have happened — there was essentially no other source of legitimate research funding for psilocybin work at the time.
Heffter has also supported research at NYU, University of New Mexico, and other sites, and has provided scientific oversight to ensure that the research it funds meets the highest methodological standards. It operates with a small staff and board of distinguished pharmacologists and clinicians.
Why It Matters
Heffter funded the first wave of modern psilocybin clinical research when institutional funders were unwilling to touch the subject. The entire research renaissance has roots in this small, determined organization's willingness to support rigorous science when no one else would.
State Legal Context
See current psilocybin laws in New Mexico.